Efficacy and Safety of Cannabidiol (CBD) Dose Adjustment in Patients With Lennox-Gastaut Syndrome (LGS): Post Hoc Analysis of Phase 3 Randomized Controlled Trial (RCT) GWPCARE3 and Open-Label Extension (OLE) Trial GWPCARE5 (P12-8.007)
Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available
10.1212/wnl.98.18_supplement.960